---
figid: PMC7961479__cancers-13-01115-g001
figlink: pmc/articles/PMC7961479/figure/cancers-13-01115-f001/
number: F1
caption: Predominant signaling pathways contributing to melanomagenesis and progression.
  Phosphorylation of receptor tyrosine kinases mesenchymal epithelial transition factor
  (c-MET), receptor-tyrosine kinase Kit (c-KIT) and vascular endothelial growth factor
  receptor (VEGFR) initiates signaling pathways resulting in proliferation, survival,
  motility, and angiogenesis. Activating mutations in downstream pathway components,
  such as reticular activating system (RAS), rapidly accelerated fibrosarcoma (RAF),
  and mitogen-activated protein kinase (MEK), confer constitutive pathway activation
  despite absence of growth signals [,,]. Activation of epithelial mesenchymal transition
  (EMT) has been implicated in acquired resistance to multiple drugs that target aberrant
  signaling.
pmcid: PMC7961479
papertitle: Resistance to Molecularly Targeted Therapies in Melanoma.
reftext: Meet Patel, et al. Cancers (Basel). 2021 Mar;13(5):1115.
pmc_ranked_result_index: '44253'
pathway_score: 0.9526056
filename: cancers-13-01115-g001.jpg
figtitle: Predominant signaling pathways contributing to melanomagenesis and progression
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7961479__cancers-13-01115-g001.html
  '@type': Dataset
  description: Predominant signaling pathways contributing to melanomagenesis and
    progression. Phosphorylation of receptor tyrosine kinases mesenchymal epithelial
    transition factor (c-MET), receptor-tyrosine kinase Kit (c-KIT) and vascular endothelial
    growth factor receptor (VEGFR) initiates signaling pathways resulting in proliferation,
    survival, motility, and angiogenesis. Activating mutations in downstream pathway
    components, such as reticular activating system (RAS), rapidly accelerated fibrosarcoma
    (RAF), and mitogen-activated protein kinase (MEK), confer constitutive pathway
    activation despite absence of growth signals [,,]. Activation of epithelial mesenchymal
    transition (EMT) has been implicated in acquired resistance to multiple drugs
    that target aberrant signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MET
  - KITLG
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - FLT1
  - FLT4
  - KDR
  - PLCB3
  - PLCB4
  - PLCG1
  - PLCB1
  - PLCE1
  - PLCD4
  - PLCD3
  - PLCB2
  - PLCD1
  - PLCG2
  - PLCZ1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - HRAS
  - KRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ARAF
  - BRAF
  - RAF1
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - TSC1
  - TSC2
  - RHEB
  - MAPK3
  - MAPK1
  - Imatinib
  - Vemurafenib
  - O
  - Dabrafenib
  - MEKPF Trametinib
  - Selumetinib
genes:
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: SCF
  symbol: SCF
  source: hgnc_alias_symbol
  hgnc_symbol: KITLG
  entrez: '4254'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: -VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: -VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: -VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: -VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: (P13K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: TSC)
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC)
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: (TSc2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Rheb)
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: ERK/MAPKP
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK/MAPKP
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Imatinib
  source: MESH
  identifier: C097613
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: O
  source: MESH
  identifier: D013481
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: MEKPF Trametinib
  source: MESH
  identifier: C560077
- word: Selumetinib
  source: MESH
  identifier: C517975
diseases: []
figid_alias: PMC7961479__F1
redirect_from: /figures/PMC7961479__F1
figtype: Figure
---
